Brouckaert P - Search Results

1

Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.

Sips M, Krykbaeva M, Diefenbach TJ, Ghebremichael M, Bowman BA, Dugast AS, Boesch AW, Streeck H, Kwon DS, Ackerman ME, Suscovich TJ, Brouckaert P, Schacker TW, Alter G. Sips M, et al. Among authors: brouckaert p. Mucosal Immunol. 2016 Nov;9(6):1584-1595. doi: 10.1038/mi.2016.12. Epub 2016 Feb 17. Mucosal Immunol. 2016. PMID: 26883728 Free PMC article.

2

HLA-C levels impact natural killer cell subset distribution and function.

Sips M, Liu Q, Draghi M, Ghebremichael M, Berger CT, Suscovich TJ, Sun Y, Walker BD, Carrington M, Altfeld M, Brouckaert P, De Jager PL, Alter G. Sips M, et al. Among authors: brouckaert p. Hum Immunol. 2016 Dec;77(12):1147-1153. doi: 10.1016/j.humimm.2016.08.004. Epub 2016 Aug 10. Hum Immunol. 2016. PMID: 27521484 Free PMC article.

3

TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production.

Cauwels A, Vandendriessche B, Bultinck J, Descamps B, Rogge E, Van Nieuwenhuysen T, Sips M, Vanhove C, Brouckaert P. Cauwels A, et al. Among authors: brouckaert p. Cardiovasc Res. 2013 Oct 1;100(1):28-35. doi: 10.1093/cvr/cvt168. Epub 2013 Jun 19. Cardiovasc Res. 2013. PMID: 23787001

4

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.

Libert C, Vink A, Coulie P, Brouckaert P, Everaerdt B, Van Snick J, Fiers W. Libert C, et al. Among authors: brouckaert p. Eur J Immunol. 1992 Oct;22(10):2625-30. doi: 10.1002/eji.1830221023. Eur J Immunol. 1992. PMID: 1327800

5

Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality.

Cauwels A, Brouckaert P, Grooten J, Huang S, Aguet M, Fiers W. Cauwels A, et al. Among authors: brouckaert p. J Immunol. 1995 Mar 15;154(6):2753-63. J Immunol. 1995. PMID: 7876546

6

Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality.

Libert C, Takahashi N, Cauwels A, Brouckaert P, Bluethmann H, Fiers W. Libert C, et al. Among authors: brouckaert p. Eur J Immunol. 1994 Sep;24(9):2237-42. doi: 10.1002/eji.1830240945. Eur J Immunol. 1994. PMID: 7522168

7

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.

Brouckaert P, Everaerdt B, Fiers W. Brouckaert P, et al. Eur J Immunol. 1992 Apr;22(4):981-6. doi: 10.1002/eji.1830220416. Eur J Immunol. 1992. PMID: 1532365

8

Mechanism of induction of tolerance to tumour necrosis factor (TNF): no involvement of modulators of TNF bioavailability or receptor binding.

Takahashi N, Brouckaert P, Bemelmans MH, Buurman WA, Fiers W. Takahashi N, et al. Among authors: brouckaert p. Cytokine. 1994 May;6(3):235-42. doi: 10.1016/1043-4666(94)90018-3. Cytokine. 1994. PMID: 8054478

9

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.

Silence K, Dreier T, Moshir M, Ulrichts P, Gabriels SM, Saunders M, Wajant H, Brouckaert P, Huyghe L, Van Hauwermeiren T, Thibault A, De Haard HJ. Silence K, et al. Among authors: brouckaert p. MAbs. 2014 Mar-Apr;6(2):523-32. doi: 10.4161/mabs.27398. Epub 2013 Dec 6. MAbs. 2014. PMID: 24492296 Free PMC article.

10

Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.

Everaerdt B, Brouckaert P, Fiers W. Everaerdt B, et al. Among authors: brouckaert p. J Immunol. 1994 May 15;152(10):5041-9. J Immunol. 1994. PMID: 8176222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page